Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 11

    1.

    In vitro and in vivo activity of first generation cephalosporins against Leptospira.

    Harris BM, Blatz PJ, Hinkle MK, McCall S, Beckius ML, Mende K, Robertson JL, Griffith ME, Murray CK, Hospenthal DR.

    Am J Trop Med Hyg. 2011 Nov;85(5):905-8.

    PMID:
    22049047
    [PubMed - indexed for MEDLINE]
    2.

    Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010.

    Mendes RE, Woosley LN, Farrell DJ, Sader HS, Jones RN.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1639-42. Epub 2011 Dec 19.

    PMID:
    22183169
    [PubMed - in process]
    3.

    Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host.

    Luangtongkum T, Shen Z, Seng VW, Sahin O, Jeon B, Liu P, Zhang Q.

    Antimicrob Agents Chemother. 2012 Mar;56(3):1300-8. Epub 2011 Dec 19.

    PMID:
    22183170
    [PubMed - in process]
    4.

    An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection.

    Miller CE, Batra R, Cooper BS, Patel AK, Klein J, Otter JA, Kypraios T, French GL, Tosas O, Edgeworth JD.

    Clin Infect Dis. 2012 Mar 1;54(5):591-600. Epub 2011 Dec 20.

    PMID:
    22186774
    [PubMed - in process]
    5.

    Outpatient antibiotic use in the United States: time to "get smarter".

    Huttner B, Samore M.

    Clin Infect Dis. 2011 Oct;53(7):640-3. No abstract available.

    PMID:
    21890768
    [PubMed - indexed for MEDLINE]
    6.

    Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.

    Hicks LA, Chien YW, Taylor TH Jr, Haber M, Klugman KP; Active Bacterial Core Surveillance (ABCs) Team.

    Clin Infect Dis. 2011 Oct;53(7):631-9.

    PMID:
    21890767
    [PubMed - indexed for MEDLINE]
    7.

    Vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: the good, the bad, and the ugly.

    Kollef MH.

    Crit Care Med. 2012 Jan;40(1):330-2. No abstract available.

    PMID:
    22179367
    [PubMed - indexed for MEDLINE]
    8.

    Veterinary hospital-acquired infections in pets with a ciprofloxacin-resistant CTX-M-15-producing Klebsiella pneumoniae ST15 clone.

    Haenni M, Ponsin C, Métayer V, Médaille C, Madec JY.

    J Antimicrob Chemother. 2012 Mar;67(3):770-1. Epub 2011 Dec 16. No abstract available.

    PMID:
    22178643
    [PubMed - in process]
    9.
    10.

    High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.

    Devasia R, Blackman A, Eden S, Li H, Maruri F, Shintani A, Alexander C, Kaiga A, Stratton CW, Warkentin J, Tang YW, Sterling TR.

    J Clin Microbiol. 2012 Apr;50(4):1390-6. Epub 2011 Dec 21.

    PMID:
    22189117
    [PubMed - in process]
    11.

    Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravir.

    Canducci F, Ceresola ER, Boeri E, Spagnuolo V, Cossarini F, Castagna A, Lazzarin A, Clementi M.

    J Infect Dis. 2011 Dec;204(11):1811-5. Epub 2011 Oct 7.

    PMID:
    21984737
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk